Quantcast
Environmental News for a Healthier Planet and Life
Евгения Матвеец / Moment / Getty Images

By Alexander Freund

Finally, some good news — soon, frontrunning vaccine developers could submit applications for fast-tracked authorizations of their coronavirus vaccines.

Three companies have reported early Phase III successes in the last several days.

Read More Show Less

EcoWatch Daily Newsletter

Pharmaceutical giant Johnson & Johnson is pausing its COVID-19 vaccine trials after a study participant fell ill. Lubo Ivanko / Getty Images

Pharmaceutical giant Johnson & Johnson (J&J) announced that it is pausing COVID-19 vaccine trials after a study participant fell ill. The announcement comes just weeks after the company said trials were in the final stages, NBC News reported.

Read More Show Less

Like many other plant-based foods and products, CBD oil is one dietary supplement where "organic" labels are very important to consumers. However, there are little to no regulations within the hemp industry when it comes to deeming a product as organic, which makes it increasingly difficult for shoppers to find the best CBD oil products available on the market.

Read More Show Less
FDA Director Stephen Hahn looks on as Donald Trump leaves the lectern during the daily coronavirus task force briefing at the White House on April 24, 2020 in Washington, DC. Drew Angerer / Getty Images

New guidelines produced by the Food and Drug Administration (FDA) to ensure the safety of a vaccine to protect against the novel coronavirus are being blocked by White House officials. The new guidelines would almost certainly guarantee that a vaccine would not be ready and approved by Election Day, according to The New York Times.

Read More Show Less

Trending

A woman swims at night with a shark in the Indian Ocean, Maldives on March 23, 2017. Andrey Nekrasov / Barcroft Media via Getty Images

Scientists are racing to create a cure for COVID-19, but the toll on sharks might be irreparable. Conservationists estimate that half a million of the predators may be killed to supply the world with a coronavirus vaccine when one is developed.

Read More Show Less
Fall is with us and winter is around the corner, so the season for colds and flu has begun — joining COVID-19. monstArrr / Getty Images

By Gudrun Heise

Just as scientists are scoring successes in coronavirus research, new problems are on their way. Fall is with us and winter is around the corner, so the season for colds and flu has begun — joining COVID-19.

Read More Show Less
Headquarters of the World Health Organization in Geneva amid the COVID-19 outbreak on Aug. 17, 2020. FABRICE COFFRINI / AFP via Getty Images

The World Health Organization (WHO) announced Monday that 64 high-income nations have joined an effort to distribute a COVID-19 vaccine fairly, prioritizing the most vulnerable citizens, as Science reported. The program is called the COVID-19 Vaccines Global Access Facility, or Covax, and it is a joint effort led by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance.

Read More Show Less
Rabbi Shmuel Herzfeld has his arm disinfected by Dr. Chao Wang during a Moderna clinical trial for a coronavirus vaccine at Meridian Clinical Research in Rockville, Maryland on July 27, 2020. Amanda Andrade-Rhoades for The Washington Post via Getty Images

The secretive blueprints for two of the leading vaccine candidates for the coronavirus were released Thursday. Pfizer and Moderna became the first two companies among the nine leading vaccine candidates to share their study designs, hoping that the disclosures will create trust and clarity for the public, as The New York Times reported.

Read More Show Less

Trending

Dr. Robert Redfield, director of the CDC and Trump participate in the daily briefing of the coronavirus task force at the White House on April 22, 2020 in Washington, DC. Drew Angerer / Getty Images

Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention (CDC), testified before the Senate health panel Wednesday and discussed a realistic timeline for a vaccine. While he said an initial vaccine for the novel coronavirus may be ready by November or December, the first batch will have an extremely limited supply that will go to the most vulnerable populations, as The Washington Post reported.

Read More Show Less
Dr. Anthony Fauci says that it may not be safe to attend movie theaters or indoor events until a year after the U.S. has a safe, effective vaccine. Pxfuel

By Jessica Corbett

As the number of confirmed Covid-19 cases in the United States surpassed 6.43 million and the nation's death toll topped 192,600, the federal government's top infectious disease expert warned Friday that life likely won't return to normal until sometime—perhaps late—in 2021.

Read More Show Less

Trending

The offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire on July 21, 2020. PAUL ELLIS / AFP via Getty Images
One of the leading candidates for a COVID-19 vaccine has been stopped after a study participant had a serious adverse reaction that is suspected to have been caused by the vaccine, as STAT News reported. The vaccine from the pharmaceutical giant AstraZeneca and the University of Oxford was in the late stages of a phase 3 trial, meaning it was being tested for safety at several sites around the country and in Europe.
Read More Show Less
Trump takes questions after delivering remarks during a news conference at the North Portico at the White House on Sept. 7, 2020 in Washington, DC. Tasos Katopodis / Getty Images

By Jake Johnson

After President Donald Trump on Monday suggested a COVID-19 vaccine could be fully developed and put to market "before a very special day" — apparently referring to the Nov. 3 presidential election — Sen. Bernie Sanders warned that Trump's ongoing politicization of the vaccine process threatens to undermine public trust and safety.

Read More Show Less
Director of the Centers for Disease Control Robert Redfield arrives for Trump's speech on vaccine development on May 15, 2020 in the Rose Garden of the White House in Washington, DC. MANDEL NGAN / AFP via Getty Images

The appearance that the Centers for Disease Control and Prevention (CDC) is taking orders from political leaders grew stronger this week as the organization told states to prepare facilities for a coronavirus vaccine before November's general election. The issue raised alarm for health experts who worry that a vaccine will be rolled out before its safety and efficacy are well established, according to The New York Times.

Read More Show Less